You are here

Justice News

Department of Justice
U.S. Attorney’s Office
District of New Hampshire

FOR IMMEDIATE RELEASE
Monday, August 31, 2020

Nashua Man Sentenced to 24 Months for Fentanyl Trafficking

            CONCORD - Martin Sheehan, 28, of Nashua, was sentenced to 24 months in federal prison for fentanyl trafficking, United States Attorney Scott W. Murray announced today.

             According to court documents and statements made in court, in October of 2018, Sheehan sold fentanyl on two occasions to a cooperating individual at locations in Nashua.  In February of 2019, law enforcement officers arrested Sheehan at a motel.  Officers recovered over 13 grams of fentanyl, which Sheehan admitted belonged to him. 

             Sheehan previously pleaded guilty on May 13, 2020.

             “Fentanyl has caused substantial damage throughout New Hampshire,” said U.S. Attorney Murray.  “Through Operation S.O.S., we are fighting back against the drug dealers who peddle fentanyl and other opioids.  We will continue to work closely with Nashua Police Department and all of our law enforcement partners to identify, prosecute, and incarcerate the drug traffickers who have threatened public health and safety by selling these deadly drugs.”

             This matter was investigated by the Nashua Police Department.  The case was prosecuted by Assistant U.S. Attorney Joachim H. Barth.

             This case is part of Operation Synthetic Opioid Surge (S.O.S.).  In July of 2018, Attorney General Jeff Sessions announced the creation of S.O.S., which is being implemented in the District of New Hampshire and nine other federal districts.  The goal of S.O.S. is to combat the large number of overdoses and deaths associated with fentanyl and other synthetic opioids.   In New Hampshire, the U.S. Attorney’s Office is focusing its efforts on prosecuting synthetic opioid trafficking cases arising in Hillsborough County, which includes Manchester and Nashua. 

     ###                 

 

 

 

Topic(s): 
Drug Trafficking
Opioids
Component(s): 
Press Release Number: 
20-108
Updated August 31, 2020